These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32609623)

  • 1. [Oncorheumatology: relationship between malignancies and musculoskeletal diseases].
    Szekanecz Z; Gomez I; Soós B; Bodoki L; Szamosi S; András C; Juhász B; Váróczy L; Antal-Szalmás P; Szodoray P; Bittner N; Árkosy P; Illés Á; Szűcs G; Dankó K; Bender T; Tamási L; Szekanecz É
    Orv Hetil; 2020 Jul; 161(28):1151-1165. PubMed ID: 32609623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases.
    Szekanecz Z; Gomez I; Soós B; Bodoki L; Szamosi S; András C; Juhász B; Váróczy L; Antal-Szalmás P; Szodoray P; Bittner N; Árkosy P; Illés Á; Szűcs G; Dankó K; Bender T; Tamási L; Szekanecz É;
    Autoimmun Rev; 2020 Nov; 19(11):102658. PubMed ID: 32942035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies.
    Abu-Shakra M; Buskila D; Ehrenfeld M; Conrad K; Shoenfeld Y
    Ann Rheum Dis; 2001 May; 60(5):433-41. PubMed ID: 11302861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatic paraneoplastic syndromes - A clinical link between malignancy and autoimmunity.
    Manger B; Schett G
    Clin Immunol; 2018 Jan; 186():67-70. PubMed ID: 28736272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of 10 patients with paraneoplastic rheumatologic musculoskeletal manifestations.
    Yamashita H; Ueda Y; Ozaki T; Tsuchiya H; Takahashi Y; Kaneko H; Kano T; Mimori A
    Mod Rheumatol; 2014 May; 24(3):492-8. PubMed ID: 24252036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature.
    Durieux V; Coureau M; Meert AP; Berghmans T; Sculier JP
    Lung Cancer; 2017 Apr; 106():102-109. PubMed ID: 28285683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastictherapy.
    Alias A; Rodriguez EJ; Bateman HE; Sterrett AG; Valeriano-Marcet J
    Bull NYU Hosp Jt Dis; 2012; 70(2):109-14. PubMed ID: 22892000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Musculoskeletal syndromes associated with malignancy (excluding hypertrophic osteoarthropathy).
    Naschitz JE; Rosner I
    Curr Opin Rheumatol; 2008 Jan; 20(1):100-5. PubMed ID: 18281865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignancies and soluble tumor antigens in rheumatic diseases.
    Szekanecz E; András C; Sándor Z; Antal-Szalmás P; Szántó J; Tamási L; Kiss E; Szekanecz Z
    Autoimmun Rev; 2006 Nov; 6(1):42-7. PubMed ID: 17110316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of paraneoplastic rheumatic syndromes and their antibody profile among patients with solid tumours.
    Rugienė R; Dadonienė J; Aleknavičius E; Tikuišis R; Distler J; Schett G; Venalis P; Venalis A
    Clin Rheumatol; 2011 Mar; 30(3):373-80. PubMed ID: 21225302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paraneoplastic rheumatism--musculoskeletal diseases as a first sign of hidden neoplasms].
    Stummvoll GH; Graninger WB
    Acta Med Austriaca; 2002; 29(1):36-40. PubMed ID: 11899753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repercussions of occult malignancy - an etiologic basis for rheumatic disease.
    Johnson AK
    Med Hypotheses; 2013 Apr; 80(4):447-51. PubMed ID: 23357672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity Mimics: Infection and Malignancy.
    Eickhoff JC; Collamer AN
    Prim Care; 2018 Jun; 45(2):343-360. PubMed ID: 29759128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paraneoplastic syndromes in rheumatology].
    Strunz PP; Schmalzing M
    Z Rheumatol; 2023 Apr; 82(3):212-219. PubMed ID: 36690750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Paraneoplastic autoimmune disorders].
    Hirokawa M
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):980-3. PubMed ID: 20567097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancies in autoimmune rheumatic diseases - a mini-review.
    Szekanecz Z; Szekanecz E; Bakó G; Shoenfeld Y
    Gerontology; 2011; 57(1):3-10. PubMed ID: 20453490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity and malignancy.
    McCarty GA
    Med Clin North Am; 1985 May; 69(3):599-615. PubMed ID: 3892193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Musculoskeletal relevance of obesity: a new approach to an old topic].
    Tamási L; Miksi Á; Kardos Z; Flórián Á; Szekanecz Z
    Orv Hetil; 2019 Nov; 160(44):1727-1734. PubMed ID: 31657254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Anti-Transcription Intermediary Factor 1γ Antibodies With Paraneoplastic Rheumatic Syndromes Other Than Dermatomyositis.
    Venalis P; Selickaja S; Lundberg K; Rugiene R; Lundberg IE
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):648-651. PubMed ID: 28704599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes.
    Solans-Laqué R; Pérez-Bocanegra C; Salud-Salvia A; Fonollosa-Plá V; Rodrigo MJ; Armadans L; Simeón-Aznar CP; Vilardell-Tarres M
    Lupus; 2004; 13(3):159-64. PubMed ID: 15119543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.